Vor Biopharma Files Definitive Proxy Statement
Ticker: VOR · Form: DEF 14A · Filed: Apr 8, 2025 · CIK: 1817229
| Field | Detail |
|---|---|
| Company | Vor Biopharma Inc. (VOR) |
| Form Type | DEF 14A |
| Filed Date | Apr 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing, governance
TL;DR
Vor Biopharma dropped its proxy statement for the 2024 fiscal year. Get ready to vote.
AI Summary
Vor Biopharma Inc. filed its definitive proxy statement (DEF 14A) on April 8, 2025, for the fiscal year ending December 31, 2024. The filing, which does not require a fee, outlines information for shareholders regarding the company's annual meeting and voting matters. Vor Biopharma is a biotechnology company focused on biological products.
Why It Matters
This filing provides shareholders with essential information for the upcoming annual meeting, including details on voting rights and company governance, which are crucial for informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders and does not inherently indicate new risks.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the proxy statement.)
- 20250408 — Filing Date (The date Vor Biopharma submitted this filing to the SEC.)
Key Players & Entities
- Vor Biopharma Inc. (company) — Registrant
- 0001817229 (company) — Central Index Key
- 2836 (company) — Standard Industrial Classification
- 02140 (dollar_amount) — ZIP Code
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit shareholder votes for their annual meeting, providing details on matters to be voted upon, director nominees, executive compensation, and other corporate governance information.
When is Vor Biopharma's fiscal year end?
Vor Biopharma's fiscal year ends on December 31st, as indicated in the filing.
What is Vor Biopharma's SIC code?
Vor Biopharma's Standard Industrial Classification (SIC) code is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
Was there a fee required for this filing?
No, the filing explicitly states 'No fee required'.
What is the company's business address?
Vor Biopharma's business address is 100 CambridgePark Drive, Suite 101, Cambridge, MA 02140.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 8, 2025 regarding Vor Biopharma Inc. (VOR).